Literature DB >> 27608644

Low IgE Is a Useful Tool to Identify STAT3 Gain-of-Function Mutations.

Matthew B Johnson1, Sarah E Flanagan1, Thomas B Martins2, Harry R Hill2, Andrew T Hattersley1, Timothy J McDonald3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27608644      PMCID： PMC7611831          DOI： 10.1373/clinchem.2016.263624

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  New childhood and adult reference intervals for total IgE.

Authors:  Thomas B Martins; Michael E Bandhauer; Ashley M Bunker; William L Roberts; Harry R Hill
Journal:  J Allergy Clin Immunol       Date:  2013-10-15       Impact factor: 10.793

2.  Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.

Authors:  Emma M Haapaniemi; Meri Kaustio; Hanna L M Rajala; Arjan J van Adrichem; Leena Kainulainen; Virpi Glumoff; Rainer Doffinger; Heikki Kuusanmäki; Tarja Heiskanen-Kosma; Luca Trotta; Samuel Chiang; Petri Kulmala; Samuli Eldfors; Riku Katainen; Sanna Siitonen; Marja-Liisa Karjalainen-Lindsberg; Panu E Kovanen; Timo Otonkoski; Kimmo Porkka; Kaarina Heiskanen; Arno Hänninen; Yenan T Bryceson; Raija Uusitalo-Seppälä; Janna Saarela; Mikko Seppänen; Satu Mustjoki; Juha Kere
Journal:  Blood       Date:  2014-10-27       Impact factor: 22.113

3.  Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.

Authors:  Joshua D Milner; Tiphanie P Vogel; Lisa Forbes; Chi A Ma; Asbjørg Stray-Pedersen; Julie E Niemela; Jonathan J Lyons; Karin R Engelhardt; Yu Zhang; Nermina Topcagic; Elisha D O Roberson; Helen Matthews; James W Verbsky; Trivikram Dasu; Alexander Vargas-Hernandez; Nidhy Varghese; Kenneth L McClain; Lina B Karam; Karen Nahmod; George Makedonas; Emily M Mace; Hanne S Sorte; Gøri Perminow; V Koneti Rao; Michael P O'Connell; Susan Price; Helen C Su; Morgan Butrick; Joshua McElwee; Jason D Hughes; Joseph Willet; David Swan; Yaobo Xu; Mauro Santibanez-Koref; Voytek Slowik; Darrell L Dinwiddie; Christina E Ciaccio; Carol J Saunders; Seth Septer; Stephen F Kingsmore; Andrew J White; Andrew J Cant; Sophie Hambleton; Megan A Cooper
Journal:  Blood       Date:  2014-10-30       Impact factor: 22.113

Review 4.  STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties.

Authors:  Trine H Mogensen
Journal:  JAKSTAT       Date:  2013-04-01

5.  Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.

Authors:  Sarah E Flanagan; Emma Haapaniemi; Mark A Russell; Richard Caswell; Hana Lango Allen; Elisa De Franco; Timothy J McDonald; Hanna Rajala; Anita Ramelius; John Barton; Kaarina Heiskanen; Tarja Heiskanen-Kosma; Merja Kajosaari; Nuala P Murphy; Tatjana Milenkovic; Mikko Seppänen; Åke Lernmark; Satu Mustjoki; Timo Otonkoski; Juha Kere; Noel G Morgan; Sian Ellard; Andrew T Hattersley
Journal:  Nat Genet       Date:  2014-07-20       Impact factor: 38.330
  5 in total
  2 in total

1.  Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.

Authors:  Lia Furlaneto Marega; Janine Schincariol Sabino; Marcus Vinicius Pedroni; Marcelo Teocchi; Carolina Lanaro; Dulcinéia Martins de Albuquerque; Irene Pereira Dos Santos; Fernando Ferreira Costa; Maria Marluce Dos Santos Vilela
Journal:  Immunol Res       Date:  2021-08-14       Impact factor: 2.829

2.  STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria.

Authors:  Merle Sauer; Jörg Scheffel; Stefan Frischbutter; Niklas Mahnke; Marcus Maurer; Thomas Burmeister; Karoline Krause; Martin Metz
Journal:  Front Immunol       Date:  2022-07-19       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.